Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH)

被引:10
作者
Pereira, R. M. R. [1 ]
Figueiredo, C. P. [1 ]
Cha, C. C. [1 ]
Caparbo, V. F. [1 ]
Oliveira, R. M. [2 ]
Franco, A. S. [1 ]
Menezes, P. R. [3 ]
de Castro, I. [4 ]
Onuchic, L. F. [5 ,6 ]
机构
[1] Univ Sao Paulo, Fac Med, Div Rheumatol, Bone Metab Lab, 455,3 Andar Reumatol,Sala 3193, BR-01246903 Sao Paulo, SP, Brazil
[2] RDO Diagnost Med, Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Fac Med, Mol Med, Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Fac Med, Div Nephrol, Sao Paulo, SP, Brazil
[6] Univ Sao Paulo, Fac Med, Div Mol Med, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Aortic calcification; Osteoprotegerin; Polymorphism; RANKL; Vertebral fractures; BONE-MINERAL DENSITY; OSTEOPROTEGERIN GENE POLYMORPHISMS; SINGLE NUCLEOTIDE POLYMORPHISMS; CHINESE POSTMENOPAUSAL WOMEN; OSTEOPOROTIC FRACTURE; LYS3ASN POLYMORPHISM; TNFRSF11B; RISK; SUSCEPTIBILITY; MASS;
D O I
10.1007/s00198-016-3664-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This is the first study analyzing concomitantly osteoprotegerin (OPG)/receptor activator of nuclear factor kappa B ligand (RANKL) polymorphisms and OPG/RANKL serum levels and their association with bone mineral density (BMD), vertebral fractures, and vascular aortic calcification in a cohort of 800 subjects in community-dwelling older individuals. Introduction Osteoprotegerin (OPG) and RANKL play an important role in osteoclast activation and differentiation as well as in vascular calcification. At present, there are no studies of OPG or RANKL gene polymorphisms in Brazilian older populations. The aim of this study was to evaluate OPG/RANKL polymorphism and their association with vertebral fractures (VFs) and aortic calcification. Methods Eight hundred subjects (497 women/303 men) were genotyped for the OPG 1181G>C (rs2073618), 163C>T (rs3102735), 245T>G (rs3134069), and 209G>A (rs3134070) and RANKL A>G (rs2277438) single-nucleotide polymorphisms (SNPs). VFs were evaluated by spine radiography (Genant's method). Aortic calcification was quantified using Kauppila's method. Results The isolated genotype analyses and single-allele frequency data showed association of OPG 163C, 245G, and 209A alleles with presence of VFs (P < 0.05). Multiple logistic regression of subjects with absence of VFs vs. those with VFs (grades II/III) revealed only OPG 209A homozygosity as a risk factor for higher-grade VFs (odds ratio (OR) = 4.17, 95 % CI 1.03-16.93, P = 0.046). Regarding aortic calcification, the isolated genotype analysis frequency data revealed a significant association of OPG 1181G, 163C, 245G, and 209A alleles with absent aortic calcification (P < 0.05). Multiple logistic regression data confirmed that the OPG 209A allele was protective for aortic calcification (OR = 0.63, 95 % CI 0.45-0.88, P = 0.007) and the OPG 1181C allele was a risk factor for aortic calcification (OR = 1.26, 95 % CI 1.00-1.58, P = 0.046). Conclusion This study showed that the OPG 209AA genotype was a risk factor for higher-grade VFs, the OPG 209A allele was protective for aortic calcification, and the OPG 1181C was a risk factor for aortic calcification, supporting the involvement of OPG polymorphisms in the analyzed phenotypes and the concept that the related pathogenesis is multifactorial.
引用
收藏
页码:3319 / 3329
页数:11
相关论文
共 50 条
  • [1] Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women
    Arko, B
    Prezelj, J
    Kocijancic, A
    Komel, R
    Marc, J
    [J]. MATURITAS, 2005, 51 (03) : 270 - 279
  • [2] Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis
    Arko, B
    Prezelj, J
    Komel, R
    Kocijancic, A
    Hudler, P
    Marc, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) : 4080 - 4084
  • [3] Official positions of the International Society for Clinical Densitometry and executive summary of the 2005 Position Development Conference
    Binkley, Neil
    Bilezikian, John P.
    Kendler, David L.
    Leib, Edward S.
    Lewiecki, E. Michael
    Petak, Steven M.
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2006, 9 (01) : 4 - 14
  • [4] RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus
    Bonfa, A. C.
    Seguro, L. P. C.
    Caparbo, V.
    Bonfa, E.
    Pereira, R. M. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (05) : 1563 - 1571
  • [5] TNFRSF11B gene polymorphisms, bone mineral density, and fractures in Slovak postmenopausal women
    Boronova, Iveta
    Bernasovska, Jarmila
    Macekova, Sona
    Petrejcikova, Eva
    Tomkova, Zlatica
    Kl'oc, Jan
    Poracova, Janka
    Blascakova, Marta Mydlarova
    Litavcova, Eva
    [J]. JOURNAL OF APPLIED GENETICS, 2015, 56 (01) : 57 - 63
  • [6] BONE MORPHOGENETIC PROTEIN EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS
    BOSTROM, K
    WATSON, KE
    HORN, S
    WORTHAM, C
    HERMAN, IM
    DEMER, LL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1800 - 1809
  • [7] Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women
    Brändström, H
    Gerdhem, P
    Stiger, F
    Obrant, KJ
    Melhus, H
    Ljunggren, Ö
    Kindmark, A
    Åkesson, K
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (01) : 18 - 24
  • [8] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    Bucay, N
    Sarosi, I
    Dunstan, CR
    Morony, S
    Tarpley, J
    Capparelli, C
    Scully, S
    Tan, HL
    Xu, WL
    Lacey, DL
    Boyle, WJ
    Simonet, WS
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1260 - 1268
  • [9] Genetic polymorphisms of OPG, RANK, and ESR1, and bone mineral density in Korean postmenopausal women
    Choi, JY
    Shin, A
    Park, SK
    Chung, HW
    Cho, SI
    Shin, CS
    Kim, H
    Lee, KM
    Lee, KH
    Kang, C
    Cho, DY
    Kang, D
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2005, 77 (03) : 152 - 159
  • [10] D'Amelio P, 2009, J Endocrinol Invest, V32, P6